Why do flat OT networks increase risk in pharmaceutical manufacturing?

Why flat OT networks amplify blast radius in a plant

A flat OT network treats too many devices, HMIs, controllers, historians, remote access paths, and support systems as if they belong to one trusted area. That design matters because a compromise rarely stays local. Once an attacker or faulty system reaches one reachable node, the same trust pattern can expose adjacent production assets and widen disruption beyond the original fault.

The core problem is not only reachability, but the lack of meaningful boundaries. In a pharmaceutical plant, where uptime, batch integrity, environmental control, and traceability all matter, broad connectivity makes it easier for one incident to become a multi-system operational event instead of a contained failure.

Flat design also weakens your ability to reason about what should talk to what. If segmentation is minimal, security teams often cannot distinguish necessary production traffic from opportunistic lateral movement. That makes containment slower, troubleshooting noisier, and recovery more disruptive because the network itself no longer reflects the process architecture.

How lateral movement turns a single compromise into plant-wide impact

In a flat OT environment, attackers do not need a sophisticated path to create damage. They can often reuse the same implicit trust that operations relies on for convenience. If they compromise a workstation, remote support channel, engineering laptop, or exposed service path, they may be able to enumerate nearby assets, reach controllers or supervisory systems, and move toward functions that affect production continuity.

This is especially dangerous in pharma because operational interdependence is high. A weakness in one segment can affect batch execution, recipe management, quality records, alarm handling, or environmental controls. Even when the initial access is limited, the ability to pivot laterally increases the chance of ransomware, sabotage, unsafe changes, or a shutdown driven by precaution rather than confirmed physical damage.

For a useful baseline on segmentation and OT architecture, NIST SP 800-82 Rev 3, OT Security Guide explains why control-system networks should be designed to limit trust and constrain movement between zones. It aligns well with plant environments where communication should be intentionally narrow, not broadly permissive.

What zone and conduit design changes in pharmaceutical manufacturing

Zone and conduit design replaces vague trust with explicit communication paths. Zones group assets with similar criticality and function, while conduits define the allowed flows between them. That structure reduces the number of places where a compromise can travel, and it gives operators a clearer basis for allowing only the traffic that a process actually needs.

In practice, this improves both resilience and governability. A lab system should not have the same reachable surface as a packaging line, and a remote vendor path should not be able to roam through the plant just because it terminates inside the same flat subnet. The more closely the network mirrors the production process, the easier it becomes to contain faults, isolate incidents, and validate that a change is safe before it reaches critical equipment.

CISA’s industrial control systems guidance at CISA Industrial Control Systems is a useful companion reference for operators who need practical ICS security and defensive guidance. For segmentation as a control principle, NIST SP 800-207 Zero Trust Architecture reinforces the idea that trust should be explicit and access should be bounded rather than assumed across the environment.

Risk and Threat Considerations

Flat OT networks increase both exposure and attack leverage. The main risk is that a compromise of one device, credential, or remote path can become a pathway to controllers, process supervision, and production-support systems that should have remained isolated. In pharma, that can force batch interruption, quality investigation, or plant shutdown even when the original issue started in a non-critical node.

Failure mechanism: Broad east-west connectivity and weak segmentation allow lateral movement, protocol abuse, and trust reuse across OT assets, so one foothold can reach more of the environment than operators intended.

Impact: The incident blast radius expands from a single device or workstation to production continuity, batch integrity, and recovery time, raising the chance of operational disruption and costly containment actions.

Practitioner Guidance

What to prioritise: Map actual process flows before you redesign the network. The useful question is not “what can connect,” but “what must connect for the process to work safely.” That distinction tells you which paths belong in the same zone and which paths should be mediated by a conduit.

What to verify: Confirm that remote access, vendor support, and engineering workstations cannot reach production systems laterally beyond their role. If a single jump host or support path can touch too many assets, treat that as a containment failure rather than an architecture convenience.

Common mistake: Treating flatness as acceptable because the plant is operational today. Flat OT often looks stable until an incident reveals how much hidden trust the design depends on, and then recovery becomes harder than the original change would have been.

Practitioner takeaway: In pharma OT, segmentation is not mainly about network hygiene, it is about limiting how far a fault, compromise, or remote session can travel before it becomes a production event.

Related resources from NHI Mgmt Group

• Why do flat IT and OT networks increase cyber risk in utilities?
• Why does IT/OT convergence increase identity risk in manufacturing?
• Why do shared VPNs and jump boxes increase lateral movement risk in OT networks?
• Why do flat networks increase risk in hospitals and other operational environments?